FUSION PROTEIN BASED ON RECOMBINANT GANODERMA IMMUNOREGULATORY PROTEIN AND HUMAN SERUM ALBUMIN, METHOD FOR PREPARATION THEREOF, AS WELL AS USE THEREOF Russian patent published in 2018 - IPC C07K14/375 C07K14/765 C07K19/00 A61K38/16 A61P35/00 A61P7/00 

Abstract RU 2665802 C2

FIELD: chemistry.

SUBSTANCE: present invention relates to the field of biotechnology, specifically to the recombinant production of a fusion protein consisting of a ganoderma immunoregulatory protein and human serum albumin (HSA), and can be used in medicine to treat leukopenia and as an antitumour agent. Obtained is an rLZ-8-HSA fusion protein, in which the C-terminus of the ganoderma immunoregulatory protein is connected to human serum albumin via a binding peptide.

EFFECT: invention improves the biological activity of rLZ-8-HSA ganoderma fusion protein and increases its in vivo half-life in comparison with rLZ-8.

10 cl, 4 dwg, 7 tbl

Similar patents RU2665802C2

Title Year Author Number
USE OF RECOMBINANT GANODERMA LUCIDUM IMMUNOMODULATORY PROTEIN (rLZ-8) IN PREPARATION OF MEDICINE FOR TREATING MELANOMA 2014
  • Chzhan Sityan
  • Sun Fej
  • Lyan Chunyan
RU2649129C2
INTERLEUKIN 15 PROTEIN COMPLEX AND USE THEREOF 2015
  • Tsyuj Syandun
  • E Sin
  • Khu Tsiyue
  • Tsuj Dunbin
  • Tao Vejkan
  • Chzhan Lyanshan
  • Sun Pyaoyan
RU2711979C2
HUMANISED ANTIBODIES AGAINST TNFα 2012
  • Chzhu Baogo
  • Tao Dehshehn
  • Sun' Bill Naj-Chao
  • Sun' Leh-Khuj King
  • Lju Zhuj Sjan'
  • Sun' Sesili Zhou-Jun'
  • Li Tsjan
  • Pehn Jujtsaj
  • Chzhan Tszinvehj
  • Khu Chzhehn'Sjan
RU2549700C1
METHODS OF INHIBITING TUMOR GROWTH BY IL-6 RECEPTOR ANTAGONIZATION 2012
  • Chzhan Li
RU2648150C2
HETERODIMERIC IL-15 PROTEIN AND USE THEREOF 2014
  • Tsyuj Syandun
  • E Sin
  • Yuan Tszitszyun
  • Chzhan Lej
  • Chen Kan
  • Chzhan Lyanshan
  • Tsao Gotsin
  • Syuj Chzhibin
  • Tao Vejkan
RU2689717C2
PROTEIN SHOWING INTERFERON-LIKE ANTIVIRAL AND ANTIPROLIFERATIVE BIOLOGICAL ACTIVITIES (VERSIONS), PROTEIN STRUCTURE, CODING POLYNUCLEOTIDE (VERSIONS), EXPRESSION VECTOR, HOST CELL, COMPOSITION AND USE OF PROTEIN AS ANTIVIRAL, ANTIPROLIFERATIVE, ANTICANCER OR IMMUNOMODULATORY AGENT AND METHOD OF TREATING CONDITION SENSITIVE TO INTERFERON-THERAPY, CANCER OR VIRAL DISEASE 2007
  • Van Khajtao
  • Mao Chunshen
  • Li Tszichzhi
  • Van Lin
  • Du Jun
  • Lju Lunbin'
  • Sjuj Tszin
  • Chzhan Zhuj
RU2469091C2
ANTIBODY SPECIFICALLY BINDING TO GLP-1R AND FUSION PROTEIN THEREOF WITH GLP-1 2014
  • Chzhan Chen
  • Tszin Shutsyan
  • Chzhan Khua
  • Van Syaofyn
  • Yao Chenkhian
RU2681857C2
COMBINED THERAPY INCLUDING VEMURAFENIB AND INTERFERON, FOR USE IN TREATING CANCER 2011
  • Dkhingra Kapil
  • Khiggins Brajan
  • Kolinski Kennet
  • Li Richard Dzh.
  • Lestini Brajan
  • Pekmen Ketrin E.
  • Su Fej
RU2592983C2
NEW VERSION OF EXENDIN OR ITS CONJUGATE 2010
  • Sjuj Majkl M.
  • Van Junsjan
  • Chzhan Inkhoj
  • Lo Sjaosu
  • Gun Njan'
  • Chzhan Litsze
  • Chzhou Sjantszjun'
RU2528734C2
NUCLEIC ACIDS ENCODING ANTIBODIES AGAINST SIALYLATED HUMAN LEWIS ANTIGEN 2014
  • Sawada, Ritsuko
  • Sun, Shu-Man
  • Scholz, Wolfgang
RU2791967C2

RU 2 665 802 C2

Authors

Chzhan Sityan

Sun Fej

Lyan Chunyan

Dates

2018-09-04Published

2014-07-11Filed